Skip to content

LeMaitre Vascular LMAT Treasury Stock

Treasury Stock at other companies

ITG
Integer HoldingsITGR
$114.23M+325%
Abbott logo
AbbottABT
$16.94B+1.9%
Baxter International logo
Baxter InternationalBAX
$10.74B-1.8%
Edwards Lifesciences logo
Edwards LifesciencesEW
$7.51B+16.5%
TFX
TeleflexTFX
$649.53M+85.4%
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's treasury stock?
LeMaitre Vascular (LMAT) reported treasury stock of $17.9M in Q1 2026.
How has LeMaitre Vascular's treasury stock changed year-over-year?
LeMaitre Vascular's treasury stock increased by 10.4% year-over-year, from $16.22M to $17.9M.
What is the long-term trend for LeMaitre Vascular's treasury stock?
Over 5 years (2020 to 2025), LeMaitre Vascular's treasury stock has grown at a 8.5% compound annual growth rate (CAGR), from $11.6M to $17.44M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.